ArticleScandinavian journal of immunology2012

Recombinant adenovirus delivery of calreticulin-ESAT-6 produces an antigen-specific immune response but no protection against a Mycobacterium tuberculosis challenge.

S C Esparza-González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.